Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Romaniuk

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Current Pharmaceutical Design|August 20, 2009
Connecting the brain and new drug targets for schizophreniaH C Whalley, J D Steele, P Mukherjee, et al.
Psychological Medicine|September 18, 2014
Dysfunction of emotional brain systems in individuals at high risk of mood disorder with depression and predictive features prior to illnessH C Whalley, J E Sussmann, L Romaniuk, et al.
Translational Psychiatry|July 5, 2012
The influence of polygenic risk for bipolar disorder on neural activation assessed using fMRIH C Whalley, M Papmeyer, E Sprooten, et al.
Psychological Medicine|September 8, 2009
Hippocampal function in schizophrenia and bipolar disorderJ Hall, H C Whalley, K Marwick, et al.
Psychological Medicine|June 11, 2016
Prospective longitudinal voxel-based morphometry study of major depressive disorder in young individuals at high familial riskT Nickson, S W Y Chan, M Papmeyer, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Dissecting heterogeneity in cortical thickness abnormalities in major depressive disorder: a large-scale ENIGMA MDD normative modelling studyJ M M Bayer, L S van Velzen, E Pozzi, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Current Pharmaceutical Design|August 20, 2009
Connecting the brain and new drug targets for schizophreniaH C Whalley, J D Steele, P Mukherjee, et al.
Psychological Medicine|September 18, 2014
Dysfunction of emotional brain systems in individuals at high risk of mood disorder with depression and predictive features prior to illnessH C Whalley, J E Sussmann, L Romaniuk, et al.
Translational Psychiatry|July 5, 2012
The influence of polygenic risk for bipolar disorder on neural activation assessed using fMRIH C Whalley, M Papmeyer, E Sprooten, et al.
Psychological Medicine|September 8, 2009
Hippocampal function in schizophrenia and bipolar disorderJ Hall, H C Whalley, K Marwick, et al.
Psychological Medicine|June 11, 2016
Prospective longitudinal voxel-based morphometry study of major depressive disorder in young individuals at high familial riskT Nickson, S W Y Chan, M Papmeyer, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Dissecting heterogeneity in cortical thickness abnormalities in major depressive disorder: a large-scale ENIGMA MDD normative modelling studyJ M M Bayer, L S van Velzen, E Pozzi, et al.
Pageof 2